Events

PhRMA hosts online and in-person events exploring science and policy issues that impact biopharmaceutical innovation and patient access to medicines. With members from the nation’s leading biopharmaceutical research companies, our events offer unique insights about the future of health in America.

November 28, 2018

Forbes Healthcare Summit

Medicine is improving at a breakneck pace; breakthroughs such as immunotherapy and genetics are changing the way we treat cancer. New drugs are being approved at an unprecedented rate while artificial intelligence and deep learning, until recently just science fiction, are actually starting to make a real difference in public health. The big question now: how can we take this kindling and set it ablaze?

Learn More

November 14, 2018

People v. Cancer

Cancer isn’t as lethal as it once was, and yet more than 600,000 Americans are estimated to die from it this year alone, making this complex set of diseases the second leading cause of death in the country. But hope is rising: big data, immuno-oncology and once-in-a-generation medical advances have led to dramatic breakthroughs. New insights into the disease have pushed boundaries, with patients receiving uniquely personalized care.

Learn More

October 3, 2018

Leading on Value: Solutions for an Evolving Health Care System

How can Washington and the private sector work together to manage the cost of health care and deliver value to consumers? The two-part event will feature health care industry CEOs discussing the evolution of the pharmaceutical business model and a reevaluation of priorities including production of personalized medicines, R&D, and care for chronic diseases.

Learn More

September 17, 2018

Turning Point: Documentary Screening + Conversation

An estimated 5.7 million people in this country have Alzheimer’s. And the search for a treatment or a cure has not been promising. In the documentary, Turning Point, filmmaker James Keach, follows a team of scientists on the front lines of Alzheimer’s research and captures the disappointment and renewed hope of those working to disrupt the disease.

Learn More

September 12, 2018

The State of Care: Disrupting Alzheimer's

The history of Alzheimer’s research has been filled with setback after setback – in fact nearly every clinical trial has failed – but it is also one marked by perseverance and renewed hope. Advancements in medical imaging have increased our understanding of how the disease strikes, and efforts are underway to develop diagnostics to treat the disease before its onset.

Learn More

July 17, 2018

The State of Care: Innovation & Access

America is a laboratory for ideas – a testing ground to advance human thought and potential from which entire industries have been born – from media and entertainment, to tech giants capitalizing on the great internet awakening, to scientific discoveries and life-saving cures.

Learn More

May 23, 2018

The State of Care: Patient Access & Affordability

The Atlantic gathered key perspectives to continue the conversation on what it costs to stay healthy in America today.

Learn More

May 3, 2018

Deconstructing the Prescription Drug Supply Chain

PhRMA and POLITICO joined together for a deep-dive conversation on the state of the pharmaceutical supply chain and what can be done to better control costs.

Learn More

November 14, 2017

Examining the Pharmaceutical Supply Chain: From Production to Patient

On November 14, 2017, RealClearPolitics—in partnership with The Value Collaborative—brought together a cross-section of experts to examine the biopharmaceutical supply chain.

Learn More

November 9, 2017

Vaccines + Immunity: Examining Modern Medicine

How can scientists and researchers effectively engage with the public? Are vaccines a matter of personal choice or public health? What will the future of vaccines look like? The Atlantic gathered stakeholders from public health officials to the medical and scientific community to explore these questions at a forum in Philadelphia.

Learn More

November 8, 2017

Future Shapers: A New Era in Cancer Innovation

A series of discussions on the innovations and solutions needed to accelerate efforts towards ending cancer as we know it including conversation with The Honorable Joseph R. Biden Jr.

Learn More

October 10, 2017

Research & Hope Awards 2017

These Awards illustrated how biopharmaceutical researchers and others in the innovation ecosystem work together to bring new medical advances to patients.

Learn More

September 19, 2017

The Future of Health Care: Unlocking & Supporting Value

The Value Collaborative partnered with Bloomberg to convene CEOs, experts and thought leaders to discuss how stakeholders are working together to unlock and support value in the future of health care.

Learn More

August 23, 2017

Precision Medicine Leaders Summit Spotlight: Paying for Personalized Value

The Value Collaborative sponsored a panel of distinguished leaders from the diagnostic, academic and patient communities.

Learn More

August 1, 2017

Innovation Pipeline: Examining Modern Medicine

In the third event of the “Examining Modern Medicine” series, The Atlantic will gather stakeholders, original thinkers and trailblazers from the nation’s innovation capital to explore what it means to put the bio into biotech.

Learn More

June 29, 2017

Turning the Tide Against Cancer National Conference Spotlight: Partnering to Deliver High-Value Care for Patients

The Turning the Tide Against Cancer National Conference convened leaders from across the oncology community to explore the role of the patient across the continuum of cancer research and care and identify strategies that policymakers might consider to support meaningful patient engagement and deliver value to patients.

Learn More

June 14, 2017

The Brain: The Next Frontier

In order to jumpstart a dialogue on the many complex issues impacting the brain, PhRMA is bringing together industry thought leaders, researchers and scientists in Los Angeles for a conversation titled “The Brain: The Next Frontier.”

Learn More

April 26, 2017

Sequencing the Genome: Examining Modern Medicine

At a forum in New York, The Atlantic will gather key stakeholders to discuss the future of the genomic era.

Learn More

April 18, 2017

Future Shapers: New Cures, New Innovators for a New Era in Mental Health

PhRMA and Axios hosted a discussion on innovation in mental health care with perspectives from experts in technology, biopharmaceutical innovation, community and public advocacy.

Learn More

February 23, 2017

A New Negotiation: Moving Payment for Medicines from Volume to Value

Across the health care system there is a movement to better pay for services based on outcomes. Join America's biopharmaceutical companies for a discussion on ways the private prescription medicine marketplace can evolve to produce and reward better value for patients.

Learn More

February 21, 2017

Through the Microscope: Examining Modern Medicine

The Pharmaceutical Research and Manufacturers of America (PhRMA) will hold its first national health care dialogue series on February 21, 2017 in Boston, Massachusetts, as part of its new GOBOLDLY campaign and The New Era of Medicine initiative.

Learn More

December 6, 2016

Tackling Diabetes: Solutions to a Complex Disease

On December 6th, 2016, PhRMA gathered members of Congress, leaders in the diabetes community, payers, providers and the biopharmaceutical industry in coordination with The Hill publication at The Newseum for a special event titled, “Tackling Diabetes: Solutions to a Complex Disease.”

Learn More

September 21, 2016

2016 Congressional Fly-In

PhRMA is bringing 60+ researchers to meet with members of Congress to discuss how they can support development of innovative treatments.

Learn More

March 9, 2016

PhRMA Annual Meeting 2016

The Annual Meeting brings together business leaders, policymakers and industry experts to take an in depth look at the state of science and health.

Learn More